Aurobindo Pharma Ltd. — documents
168 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_36105_12662_29052018055408_WEB.xml | e0f32ee116592cb2 |
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_36123_12697_29052018063057_WEB.xml | c46edd31e995c1c0 |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_40617_58875_13112018123658_WEB.xml | 1fd9d70e2b41dd7c |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_40617_58875_13112018123658_WEB_2.x | f16fafae3f6200d4 |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_42485_80512_08022019122455_WEB.xml | 24a96550b9ba5a5f |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_42485_80512_08022019122455_WEB_2.x | 48eee35d9be33c84 |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_50218_166178_13112019042933_WEB.xm | 87c2795fce8a09de |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_50270_166486_13112019054242_WEB.xm | 217c0089e190abc7 |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_52712_216024_07022020113354_WEB.xm | e7cca8c34a076218 |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_52713_216028_07022020113635_WEB.xm | ae510999e4074fe8 |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55596_263405_04062020010438_WEB.xm | c65a868566483b36 |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55597_263408_04062020010720_WEB.xm | bd9e44ac324ce137 |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_60029_306050_13082020105230_WEB.xm | fbfeab25b86ea6a9 |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_60030_306054_13082020105707_WEB.xm | 7451a6a0c1744920 |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_64595_360040_12112020023217_WEB.xm | d88bce00cdfb1bd7 |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_64597_360048_12112020023653_WEB.xm | a9effd67302dea46 |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67874_405707_11022021124423_WEB.xm | 77b3cc2202370a7a |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67879_405722_11022021124944_WEB.xm | fae7ea4d29604f6d |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_70771_453830_31052021055540_WEB.xm | 294621b35ba357c8 |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_70772_453845_31052021061054_WEB.xm | 088c985a841837f5 |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_75233_504977_12082021085820_WEB.xm | ed25a258132683fb |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_75234_504984_12082021090233_WEB.xm | 2810665ee237ab50 |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_77994_552742_09112021032759_WEB.xm | 7c066e9d6ba87c7e |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_77997_552748_09112021033154_WEB.xm | 49e6aa132d860048 |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_81847_605994_10022022010821_WEB.xm | 7cb33f3c70278599 |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_81850_606004_10022022011550_WEB.xm | 5d1a3fc7c9589341 |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_86999_670532_31052022053520_WEB.xm | e6f10e172d63613a |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_87002_670551_31052022053711_WEB.xm | 4e0281684f0d84b8 |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_654877_2540_12082022115308_WEB.xml | a3e71a6e74fdb643 |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_654890_2540_12082022115308_WEB.xml | 4cefe0d9d0089ad0 |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_866624_4881_12112022203610_WEB.xml | dd3fcafc5e931ad5 |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_866751_4881_12112022203639_WEB.xml | 9c3fd9050d6e9b13 |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89309_790438_10022023120852.xml | 1b0ed442f09f14d7 |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89310_790441_10022023121149.xml | 0455928ec7f0b65a |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_93207_855628_27052023100858.xml | 08e2a601091a3c9d |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_93209_855635_27052023101002.xml | 70152aad0dc438f7 |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_97024_917549_12082023075206.xml | 7d332d5bde347107 |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_97029_917568_12082023075753.xml | 22d1c8f573129433 |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100244_984813_10112023020858.xml | 844a8d491c5a5ae5 |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100248_984831_10112023021212.xml | 25f05680d1b72801 |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_103388_1051463_10022024074143.xml | 780362f02f61d2b0 |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_103389_1051468_10022024074438.xml | f465ae3f24281c57 |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_107278_1139436_25052024093038.xml | ed51ab5b65ed3270 |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_107279_1139442_25052024093242.xml | 478eecaa0425564c |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_111334_1220634_10082024080451.xml | 23b078cc0de357fe |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_111335_1220639_10082024080709.xml | e5007ae67a810a3f |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_114798_1303289_09112024085916.xml | fbe6b2924b6358fa |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_114799_1303292_09112024090136.xml | 63609d081a6a5bd0 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_118971_1373813_06022025100416.xml | e44d73e6f22f4de0 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_118972_1373816_06022025100611.xml | 7d890cbb2d4a9509 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1452169_27052025 | c09c0ec784fafacf |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1452173_27052025 | 5fbb7bfbe64377d8 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1502262_04082025 | 6c71dbd77012f84d |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1502271_04082025 | 5aafed2a544165b3 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1566248_05112025 | f3b67a566e55dfd8 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1566250_05112025 | abb7520ce4cbbcc7 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1622073_09022026 | a2dc82e4a2352715 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1622074_09022026 | 741e72ed10c38640 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1671038_21052026 | 0788a34710e45906 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1671039_21052026 | 3c516c6928949825 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1708705_05082026 | 44b6d13f21392c7b |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1708706_05082026 | 83d64867e6dbf9e2 |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-08-10T12:03:58 | Main_Ind_As_524804_108201812347.xml | c4f41c3e4f3143e6 |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-08-10T12:03:58 | Main_Ind_As_524804_108201812546.xml | 49a21c5b773b1a68 |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-13T13:06:31 | Main_Ind_As_524804_13112018114045.xml | 5ba93b79f7ce5d5e |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-13T13:06:31 | Main_Ind_As_524804_13112018114228.xml | 0dce65cbad6eb50d |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-02-08T11:36:13 | Main_Ind_As_524804_822019113555.xml | 2892a0dbff9a0ddd |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-02-08T11:36:13 | Main_Ind_As_524804_822019113738.xml | 9e44d2211c3d03a4 |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-29T13:06:34 | Main_Ind_As_524804_29520191231.xml | 4dd75aae36f374b8 |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-29T13:06:34 | Main_Ind_As_524804_295201912514.xml | 64a35b3b087245b8 |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-08-08T11:28:47 | Main_Ind_As_524804_882019112835.xml | a0f09169cb6b5458 |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-08-08T11:28:47 | Main_Ind_As_524804_882019113026.xml | f9410adc38700c66 |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-11-13T17:43:25 | Main_Ind_As_524804_13112019171226.xml | abd67db6e15863d9 |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-11-13T17:43:25 | Main_Ind_As_524804_1311201917728.xml | c1c321efe6afaadd |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-07T12:13:10 | Main_Ind_As_524804_722020112034.xml | 6ae1ad97601859fc |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-07T12:13:10 | Main_Ind_As_524804_72202011225.xml | ff5407ae7b465658 |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-06-04T12:59:55 | Main_Ind_As_524804_462020125929.xml | e65f69b58b47be80 |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-06-04T12:59:55 | Main_Ind_As_524804_46202013038.xml | cb53fbaedd592c59 |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-08-13T10:45:31 | Main_Ind_As_524804_1382020104518.xml | 338f20ad88b49081 |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-08-13T10:45:31 | Main_Ind_As_524804_1382020104711.xml | 68741903fa5b9c39 |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-12T15:20:31 | Main_Ind_As_524804_12112020141439.xml | 37676308377df5bd |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-12T15:20:31 | Main_Ind_As_524804_12112020141639.xml | ff744cdf1470a2e0 |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-11T13:04:32 | Main_Ind_As_524804_1122021122316.xml | 67a77851dd2de383 |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-11T13:04:32 | Main_Ind_As_524804_112202112252.xml | 58c5e03b4febebc6 |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-31T18:43:28 | Main_Ind_As_524804_3152021174552.xml | b042e1cee4eb949e |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-31T18:43:28 | Main_Ind_As_524804_3152021174718.xml | eb6d2df9407e3d76 |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-08-13T08:49:59 | Main_Ind_As_524804_1282021205237.xml | 8a94f6a0823d5e45 |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-08-13T08:49:59 | Main_Ind_As_524804_128202120558.xml | cc823ba935d2b1e2 |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-09T15:54:46 | Main_Ind_As_524804_911202115148.xml | e12c9542e8bdc516 |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-09T15:54:46 | Main_Ind_As_524804_9112021151543.xml | 52202f43dc2df2e3 |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-10T13:33:44 | Main_Ind_As_524804_1022022125257.xml | 7af17e2b667dfb13 |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-10T13:33:44 | Main_Ind_As_524804_1022022125433.xml | a20793e4345c2f96 |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-31T17:27:12 | Main_Ind_As_524804_315202216345.xml | 7bfd27f8513f8386 |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-31T17:27:12 | Main_Ind_As_524804_315202216613.xml | b91673a165971dbf |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-08-13T11:34:34 | Main_Ind_As_524804_1282022114255.xml | 4cefe0d9d0089ad0 |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-08-13T11:34:34 | Main_Ind_As_524804_128202211454.xml | a3e71a6e74fdb643 |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-13T13:36:30 | Main_Ind_As_524804_12112022202848.xml | dd3fcafc5e931ad5 |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-13T13:36:30 | Main_Ind_As_524804_12112022203054.xml | 9c3fd9050d6e9b13 |
| Annual report | 2016-03-31 | grade A | 2016-08-29T00:00:00 | 5248040316.pdf | 146b43605b79bfaf |
| Annual report | 2017-03-31 | grade A | 2017-09-04T00:00:00 | 5248040317.pdf | 49391e780395bf62 |
| Annual report | 2018-03-31 | grade A | 2018-09-04T00:00:00 | 5248040318.pdf | 477e28f59cb28960 |
| Annual report | 2019-03-31 | grade B | 2019-08-05T00:00:00 | 5248040319.pdf | aeda7fd2ee4cd60e |
| Annual report | 2020-03-31 | grade A | 2020-08-04T00:00:00 | 5248040320.pdf | 2863968b480da8c7 |
| Annual report | 2021-03-31 | grade A | 2021-08-04T00:00:00 | 69269524804_25_08_21.pdf | 3a03c28cc93cf5da |
| Annual report | 2022-03-31 | grade A | 2022-07-09T00:00:00 | 73589524804.pdf | 4f1ea2e55a0a9006 |
| Annual report | 2023-03-31 | grade A | 2023-08-01T19:17:40.34 | 0aa8e6e6-da93-48a3-a74d-9d50683dc2a7.pdf | 561fc8010c71fbeb |
| Annual report | 2024-03-31 | grade A | 2024-08-05T17:40:31.51 | c2f11ada-795d-4215-acbf-3df412cdc882.pdf | 9e092bb4d317944f |
| Annual report | 2025-03-31 | grade A | 2025-08-14T15:22:52.49 | 0e3a5b88-6f3b-4a5d-8d07-7186fd4b1f25.pdf | e97121aee57558ad |
| Annual report | 2026-03-31 | grade A | 2026-08-03T18:32:54.987 | ec25ad91-8862-484e-b848-03b3d5e520c9.pdf | a4a58bb8f864e801 |
| Concall | 2018-12-31 | TRANSCRIPT | — | Date_20190222_Aurobindo Pharma Ltd._Concal_Q3FY19.pdf | 883a5163861bc054 |
| Concall | 2019-03-31 | TRANSCRIPT | — | Date_20190614_Aurobindo Pharma Ltd._Concal_Q4FY19.pdf | 5d4c28b4cdca4e2f |
| Concall | 2019-06-30 | TRANSCRIPT | — | Date_20190819_Aurobindo Pharma Ltd._Concal_Q1FY20.pdf | 43cf62fc1c6a4ad6 |
| Concall | 2019-09-30 | TRANSCRIPT | — | Date_20191128_Aurobindo Pharma Ltd._Concal_Q2FY20.pdf | 6b3f78033e25ddf0 |
| Concall | 2019-12-31 | TRANSCRIPT | — | Date_20200224_Aurobindo Pharma Ltd._Concal_Q3FY20.pdf | 71a541834f27d997 |
| Concall | 2020-03-31 | TRANSCRIPT | — | Date_20200618_Aurobindo Pharma Ltd._Concal_Q4FY20.pdf | 5d47a8fe09d2e9ee |
| Concall | 2020-06-30 | TRANSCRIPT | — | Date_20200825_Aurobindo Pharma Ltd._Concal_Q1FY21.pdf | ac823395d7433b6b |
| Concall | 2020-09-30 | TRANSCRIPT | — | Date_20201127_Aurobindo Pharma Ltd._Concal_Q2FY21.pdf | 9ed27f04cb1d5e5c |
| Concall | 2020-12-31 | TRANSCRIPT | — | Date_20210225_Aurobindo Pharma Ltd._Concal_Q3FY21.pdf | 546acbb4f35e4f97 |
| Concall | 2021-03-31 | TRANSCRIPT | — | Date_20210611_Aurobindo Pharma Ltd._Concal_Q4FY21.pdf | 8087f7872bea8a79 |
| Concall | 2021-06-30 | TRANSCRIPT | — | Date_20210825_Aurobindo Pharma Ltd._Concal_Q1FY22.pdf | c21ee4e10259945e |
| Concall | 2021-09-30 | TRANSCRIPT | — | Date_20211119_Aurobindo Pharma Ltd._Concal_Q2FY22.pdf | 94b7b2b26b604f2c |
| Concall | 2021-12-31 | TRANSCRIPT | — | Date_20220217_Aurobindo Pharma Ltd._Concal_Q3FY22.pdf | 31e83470674edf93 |
| Concall | 2022-03-31 | TRANSCRIPT | — | Date_20220606_Aurobindo Pharma Ltd._Concal_Q4FY22.pdf | 440e1440685f56a7 |
| Concall | 2022-06-30 | TRANSCRIPT | — | Date_20220819_Aurobindo Pharma Ltd._Concal_Q1FY23.pdf | 532eba47fd12cd51 |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221118_Aurobindo Pharma Ltd._Concal_Q2FY23.pdf | a60d0ae1a9d6508b |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230217_Aurobindo Pharma Ltd._Concal_Q3FY23.pdf | 70182399c9b8b19d |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20240216_Aurobindo Pharma Ltd._Concal_Q3FY23.pdf | 0516a26e4a765b67 |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230601_Aurobindo Pharma Ltd._Concal_Q4FY23.pdf | e713eef7e54c3617 |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230818_Aurobindo Pharma Ltd._Concal_Q1FY24.pdf | 441a084d26064e5f |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20240816_Aurobindo Pharma Ltd._Concal_Q1FY24.pdf | 80a20819d1233c24 |
| Concall | 2023-09-30 | TRANSCRIPT | — | Date_20231115_Aurobindo Pharma Ltd._Concal_Q2FY24.pdf | 91098460259b90a9 |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20240531_Aurobindo Pharma Ltd._Concal_Q4FY24.pdf | d3259970482478a3 |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241118_Aurobindo Pharma Ltd._Concal_Q2FY25.pdf | 53d5ecd2cb455302 |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20260216_Aurobindo Pharma Ltd._Concal_Q3FY25.pdf | 3e637c21c152b76f |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250213_Aurobindo Pharma Ltd._Concal_FYFY25.pdf | 5e9a4cf045cc0513 |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250602_Aurobindo Pharma Ltd._Concal_Q4FY25.pdf | e920dfcb4c3b95dc |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250808_Aurobindo Pharma Ltd._Concal_Q1FY26.pdf | 7a5b02a07902382f |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251111_Aurobindo Pharma Ltd._Concal_Q2FY26.pdf | 5712e907c4946c93 |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260527_Aurobindo Pharma Ltd._Concal_Q4FY26.pdf | caf18c16cc922481 |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260813_Aurobindo Pharma Ltd._Concal_Q1FY27.pdf | c220b173b3f2e6e3 |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161518_529614_12102021031829_WEB.xml | 15f97250442842ea |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164755_589872_17012022031323_WEB.xml | 5279b2da9c1953c2 |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_167156_636995_16042022110032_WEB.xml | 9f825d050b4cd9bb |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169862_692995_18072022035024_WEB.xml | ba7b19bb2beccde3 |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_172080_735322_20102022100151_WEB.xml | 2df321387175dffa |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_174438_768811_17012023120310_WEB.xml | af447f0ac8deb205 |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176580_818733_14042023122410_WEB.xml | 50a0b80330f2525b |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179603_891661_19072023122205_WEB.xml | 636cdc9c6e011415 |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_181652_953216_16102023024339_WEB.xml | 352cd7ec8dc69206 |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183359_1010330_08012024025912_WEB.xm | 59b6daaaed688047 |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_185835_1081377_05042024033430_WEB.xm | 7c180b4ee7d5f9bd |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_188803_1175631_09072024121105_WEB.xm | 0a4f7d212c4a914d |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191793_1267675_14102024125257_WEB.xm | a3c1ee8fc5eac121 |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_194478_1343799_13012025043701_WEB.xm | b0f7ad5a46130859 |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197288_1415039_15042025054751_WEB.xm | e7766b0a677a754f |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1482952_15072025022756_WEB.xml | ceaae362d69f8fc8 |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1546245_13102025043353_WEB.xml | 41882b53c4565a22 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1599979_13012026051655_WEB.xml | c3d5b392cb3d5289 |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1653158_17042026040030_WEB.xml | 8f1bd7c2fce1698f |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1693124_15072026033059_WEB.xml | dd88c461edd1f94f |
| Related-party XBRL | 2022-03-31 | — | — | RPT_AUROPHARMA_10082022145605.xml | e9a0f2fd60dd3fae |
| Related-party XBRL | 2022-09-30 | — | — | RPT_AUROPHARMA_25112022230112.xml | 86db6d2e302fc3d1 |
| Related-party XBRL | 2022-09-30 | — | — | RPT_AUROPHARMA_29122022150426.xml | 48616cef01239e53 |
| Related-party XBRL | 2023-03-31 | — | — | RPT_855510_27052023082734_WEB.xml | 6df01bf32f15927a |
| Related-party XBRL | 2023-03-31 | — | — | RPT_900486_26072023040458_WEB.xml | 9dcb33b5f27b4bd2 |
| Related-party XBRL | 2023-09-30 | — | — | RPT_984062_09112023085100_WEB.xml | d02b02b445d51521 |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1139371_25052024073133_WEB.xml | 192b65fac982e013 |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1303297_09112024090949_WEB.xml | 183b4f1cbf4e76f1 |